Sino Biopharmaceutical | 1177 - Ebitda

股票价格

5.92

每天变化

-0.04 -0.67%

每月一次

-2.95%

每年

65.36%

Q2 预测

5.73

金融业

CNY

CNY 74.89B

现金及等价物

CNY 3.38B

CNY 3.08B

CNY 33.82B

CNY 24.85B

CNY 9.71B

股息收益率

CNY 1.35

CNY 5.18B

CNY 2.59B

CNY 25.81K

EPS每股收益

CNY -0.06

股本和储备

CNY 34B

CNY 10.5B

债务利息支出

CNY 76.87M

CNY 3.08B

CNY 111.24B

CNY 3.39B

CNY 12.39B

CNY 5.18B

普通股股本

CNY 17.89B

17.03

CNY 1.81B

CNY 14.26B

销售和管理费用

CNY 7.54B

CNY 1.84B

贸易债权人

CNY 2.82B

应收帐款人

CNY 8.45B

	Ebitda	更改		日
Akebia Therapeutics	USD 14.03M		17.19M	2025-03
Alaunos Therapeutics	USD -21.02M		1.33M	2021-03
Avita Medical	AUD -9.69M		12.21M	2025-12
Cspc Pharmaceutical	CNY 2.19B		21.88M	2024-12
Dianthus Therapeutics	USD -40.19M		5.36M	2025-09
Ionis Pharmaceuticals	USD -157.12M		307.36M	2025-09
IQVIA Holdings	USD 1.05B		97M	2025-12
Jiangsu Hengrui	CNY 2.98B		890.87M	2025-06
Moderna	USD -790M		582M	2025-12
Organon & Co	USD 383M		135M	2025-12
Revvity	USD 248.91M		48.52M	2025-12
Sino Biopharmaceutical	CNY 2.59B		1.57B	2024-12
Tectonic Therapeutic	USD -21.18M		365K	2025-12
Viatris	USD 1B		151.5M	2025-12
Xeris Pharmaceuticals	USD 25.09M		7.67M	2025-12